References analysis of the Wikipedia article "Diagnosis of multiple sclerosis" in the English version

doi.org

Oki S (February 2018). "Novel mechanism and biomarker of chronic progressive multiple sclerosis". Clinical and Experimental Neuroimmunology. 9 (1): 25–34. doi:10.1111/cen3.12449.

McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Annals of Neurology. 50 (1): 121–127. CiteSeerX 10.1.1.466.5368. doi:10.1002/ana.1032. PMID 11456302. S2CID 13870943.

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. (December 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Annals of Neurology. 58 (6): 840–846. CiteSeerX 10.1.1.604.2677. doi:10.1002/ana.20703. PMID 16283615. S2CID 54512368.

Compston A, Coles A (October 2008). "Multiple sclerosis". Lancet. 372 (9648): 1502–1517. doi:10.1016/S0140-6736(08)61620-7. PMID 18970977. S2CID 195686659.

Trojano M, Paolicelli D (November 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurological Sciences. 22 (8 Suppl 2): S98-102. doi:10.1007/s100720100044. PMID 11794488. S2CID 3057096.

Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". Seminars in Neurology. 28 (1): 46–55. doi:10.1055/s-2007-1019127. PMID 18256986.

Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". Journal of Neuroimmunology. 180 (1–2): 17–28. doi:10.1016/j.jneuroim.2006.07.006. PMID 16945427. S2CID 22724352.

Gronseth GS, Ashman EJ (May 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 54 (9): 1720–1725. doi:10.1212/wnl.54.9.1720. PMID 10802774.

Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clinical Neurology and Neurosurgery. 106 (3): 147–158. doi:10.1016/j.clineuro.2004.02.004. PMID 15177763. S2CID 23452341.

Tremlett H, Okuda DT, Lebrun-Frenay C (October 2021). "The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients - No". Multiple Sclerosis. 27 (12): 1824–1826. doi:10.1177/13524585211035951. PMC 8521363. PMID 34494923.

Yusuf F, Wijnands JM, Kingwell E, Zhu F, Evans C, Fisk JD, et al. (February 2021). "Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome". Multiple Sclerosis. 27 (2): 290–302. doi:10.1177/1352458520908163. PMID 32250183. S2CID 214810456.

Disanto G, Zecca C, MacLachlan S, Sacco R, Handunnetthi L, Meier UC, et al. (June 2018). "Prodromal symptoms of multiple sclerosis in primary care". Annals of Neurology. 83 (6): 1162–1173. doi:10.1002/ana.25247. PMID 29740872. S2CID 13691058.

Tremlett H, Marrie RA (January 2021). "The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities". Multiple Sclerosis. 27 (1): 6–12. doi:10.1177/1352458520914844. PMID 32228281. S2CID 214750591.

Spelman T, Magyari M, Piehl F, Svenningsson A, Rasmussen PV, Kant M, et al. (October 2021). "Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies". JAMA Neurology. 78 (10): 1197–1204. doi:10.1001/jamaneurol.2021.2738. PMC 8369379. PMID 34398221. S2CID 237095594.

Claflin SB, Campbell JA, Mason DF, Kalincik T, Simpson-Yap S, Norman R, et al. (August 2021). "The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis". Multiple Sclerosis. 28 (5): 831–841. doi:10.1177/13524585211035948. PMID 34387513. S2CID 236997752.

Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. (March 2009). "Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome". Neurology. 72 (9): 800–805. doi:10.1212/01.wnl.0000335764.14513.1a. PMID 19073949. S2CID 9981947.

Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, et al. (April 2018). "Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome". Brain. 141 (4): 1085–1093. doi:10.1093/brain/awy021. PMID 29452342.

Hottenrott T, Dersch R, Berger B, Rauer S, Eckenweiler M, Huzly D, Stich O (December 2015). "The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort". Fluids and Barriers of the CNS. 12 (1): 27. doi:10.1186/s12987-015-0024-8. PMC 4677451. PMID 26652013.

Kotulska-Jóźwiak K, Pacheva I, Patrova A, Jurkiewicz EJ, Ivanov I, Kuczyński D, Geneva I (18 February 2019). "Lyme Disease or Multiple Sclerosis? Two cases with overlapping features". Journal of the International Child Neurology Association: 12. doi:10.17724/jicna.2018.112. S2CID 149606491.

Lublin FD, Reingold SC (April 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". Neurology. 46 (4): 907–911. doi:10.1212/WNL.46.4.907. PMID 8780061. S2CID 40213123.

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. (July 2014). "Defining the clinical course of multiple sclerosis: the 2013 revisions". Neurology. 83 (3): 278–286. doi:10.1212/WNL.0000000000000560. PMC 4117366. PMID 24871874.

Pittock SJ, Rodriguez M (2008). "Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications". Advances in multiple Sclerosis and Experimental Demyelinating Diseases. Current Topics in Microbiology and Immunology. Vol. 318. pp. 1–17. doi:10.1007/978-3-540-73677-6_1. ISBN 978-3-540-73676-9. PMID 18219812.

Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". The Lancet. Neurology. 4 (5): 281–288. doi:10.1016/S1474-4422(05)70071-5. PMID 15847841. S2CID 36401666.

Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". The Lancet. Neurology. 5 (4): 343–354. doi:10.1016/S1474-4422(06)70410-0. PMID 16545751. S2CID 39503553.

Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". The Lancet. Neurology. 6 (10): 903–912. doi:10.1016/S1474-4422(07)70243-0. hdl:1871/24666. PMID 17884680. S2CID 31389841.

Stadelmann C, Brück W (November 2004). "Lessons from the neuropathology of atypical forms of multiple sclerosis". Neurological Sciences. 25 (Suppl 4): S319–S322. doi:10.1007/s10072-004-0333-1. PMID 15727225. S2CID 21212935.

Ntranos A, Lublin F (October 2016). "Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space". Current Neurology and Neuroscience Reports. 16 (10): 90. doi:10.1007/s11910-016-0688-8. PMID 27549391. S2CID 4498332.

Marriott JJ, O'Connor PW (2010). "Differential Diagnosis and Diagnostic Criteria for Multiple Sclerosis". Multiple Sclerosis 3. Blue Books of Neurology. Vol. 35. pp. 19–42. doi:10.1016/B978-1-4160-6068-0.00002-4. ISBN 978-1-4160-6068-0. S2CID 68141248.

Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. (November 1997). "Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis". Brain. 120 (11): 2059–2069. doi:10.1093/brain/120.11.2059. hdl:1871/24709. PMID 9397021.

handle.net

hdl.handle.net

Atlas: Multiple Sclerosis Resources in the World, 2008. World Health Organization & Multiple Sclerosis International Federation. 2008. pp. 15–16. hdl:10665/43968. ISBN 978-92-4-156375-8.

nih.gov

pubmed.ncbi.nlm.nih.gov

Tsang BK, Macdonell R (December 2011). "Multiple sclerosis- diagnosis, management and prognosis". Australian Family Physician. 40 (12): 948–955. PMID 22146321.

Compston A, Coles A (October 2008). "Multiple sclerosis". Lancet. 372 (9648): 1502–1517. doi:10.1016/S0140-6736(08)61620-7. PMID 18970977. S2CID 195686659.

Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". Seminars in Neurology. 28 (1): 46–55. doi:10.1055/s-2007-1019127. PMID 18256986.

Tintoré M, Rovira A, Martínez MJ, Rio J, Díaz-Villoslada P, Brieva L, et al. (April 2000). "Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis". AJNR. American Journal of Neuroradiology. 21 (4): 702–706. PMC 7976636. PMID 10782781.

ncbi.nlm.nih.gov

psu.edu

citeseerx.ist.psu.edu

semanticscholar.org

api.semanticscholar.org

Compston A, Coles A (October 2008). "Multiple sclerosis". Lancet. 372 (9648): 1502–1517. doi:10.1016/S0140-6736(08)61620-7. PMID 18970977. S2CID 195686659.

Diagnosis of multiple sclerosis (English Wikipedia)

doi.org

handle.net

hdl.handle.net

nationalmssociety.org

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

psu.edu

citeseerx.ist.psu.edu

qmul.ac.uk

qmro.qmul.ac.uk

semanticscholar.org

api.semanticscholar.org

web.archive.org

worldwidejournals.com